Voyager Therapeutics VYGR is preparing to release its quarterly earnings on Tuesday, 2024-11-12. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Voyager Therapeutics to report an earnings per share (EPS) of $-0.49.
Investors in Voyager Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
Last quarter the company beat EPS by $0.23, which was followed by a 14.04% drop in the share price the next day.
Here's a look at Voyager Therapeutics's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.41 | -0.44 | -0.29 | -0.58 |
| EPS Actual | -0.18 | -0.20 | 1.25 | -0.59 |
| Price Change % | -14.000000000000002% | 0.0% | -7.000000000000001% | 5.0% |
Performance of Voyager Therapeutics Shares
Shares of Voyager Therapeutics were trading at $7.13 as of November 08. Over the last 52-week period, shares are up 8.12%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Voyager Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
